BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 38512513)

  • 1. Bilateral adrenal primary tumor in Stage 4S neuroblastoma: The Italian experience and review of the literature.
    Montalto S; Sertorio F; Podda M; Sorrentino S; Di Cataldo A; Provenzi M; Nonnis A; D'Ippolito C; Corrias MV; De Bernardi B
    Pediatr Hematol Oncol; 2022 Aug; 39(5):441-452. PubMed ID: 35139733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Neuroblastoma Patient Risk Groups, Outcomes, and Treatment Response Using Machine Learning Methods: A Review.
    Jahangiri L
    Med Sci (Basel); 2024 Jan; 12(1):. PubMed ID: 38249081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma.
    Li S; Mi T; Jin L; Liu Y; Zhang Z; Wang J; Wu X; Ren C; Wang Z; Kong X; Liu J; Luo J; He D
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):148. PubMed ID: 38512513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma.
    Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H
    J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
    Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
    Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma.
    Meng X; Fang E; Zhao X; Feng J
    Cancer Med; 2020 Jun; 9(11):3800-3815. PubMed ID: 32216054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome.
    Cornero A; Acquaviva M; Fardin P; Versteeg R; Schramm A; Eva A; Bosco MC; Blengio F; Barzaghi S; Varesio L
    BMC Bioinformatics; 2012 Mar; 13 Suppl 4(Suppl 4):S13. PubMed ID: 22536959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis.
    Meng X; Li H; Fang E; Feng J; Zhao X
    Front Oncol; 2020; 10():1411. PubMed ID: 32974147
    [No Abstract]   [Full Text] [Related]  

  • 9. TCGAplot: an R package for integrative pan-cancer analysis and visualization of TCGA multi-omics data.
    Liao C; Wang X
    BMC Bioinformatics; 2023 Dec; 24(1):483. PubMed ID: 38105215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-30e-5p-mediated FOXD1 promotes cell proliferation by blocking cellular senescence and apoptosis through p21/CDK2/Rb signaling in head and neck carcinoma.
    Wu T; Yang Z; Chen W; Jiang M; Xiao Z; Su X; Jiao Z; Yu Y; Chen S; Song M; Yang A
    Cell Death Discov; 2023 Aug; 9(1):295. PubMed ID: 37563111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. scDrug: From single-cell RNA-seq to drug response prediction.
    Hsieh CY; Wen JH; Lin SM; Tseng TY; Huang JH; Huang HC; Juan HF
    Comput Struct Biotechnol J; 2023; 21():150-157. PubMed ID: 36544472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism.
    Watanabe K; Kimura S; Seki M; Isobe T; Kubota Y; Sekiguchi M; Sato-Otsubo A; Hiwatari M; Kato M; Oka A; Koh K; Sato Y; Tanaka H; Miyano S; Kawai T; Hata K; Ueno H; Nannya Y; Suzuki H; Yoshida K; Fujii Y; Nagae G; Aburatani H; Ogawa S; Takita J
    Oncogene; 2022 Nov; 41(46):4994-5007. PubMed ID: 36319669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell transcriptomics of neuroblastoma identifies chemoresistance-associated genes and pathways.
    Avitabile M; Bonfiglio F; Aievola V; Cantalupo S; Maiorino T; Lasorsa VA; Domenicotti C; Marengo B; Zbyněk H; Vojtěch A; Iolascon A; Capasso M
    Comput Struct Biotechnol J; 2022; 20():4437-4445. PubMed ID: 36051886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer.
    Liu Z; Liu L; Weng S; Guo C; Dang Q; Xu H; Wang L; Lu T; Zhang Y; Sun Z; Han X
    Nat Commun; 2022 Feb; 13(1):816. PubMed ID: 35145098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing.
    Szymansky A; Kruetzfeldt LM; Heukamp LC; Hertwig F; Theissen J; Deubzer HE; Willing EM; Menon R; Fuchs S; Thole T; Schulte S; Schmelz K; Künkele A; Lang P; Fuchs J; Eggert A; Eckert C; Fischer M; Henssen AG; Rodriguez-Fos E; Schulte JH
    J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442335
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.